Improving care at cystic fibrosis centers through quality improvement

Seminars in Respiratory and Critical Care Medicine

Volumn 30, Issue 5, 2009, Pages 547-558

  Kraynack, Nathan C ^a   McBride, John T ^a  

^a AKRON CHILDREN'S HOSPITAL   (United States)

Author keywords

Clinical microsystems; Cystic fibrosis; Pulmonary exacerbation; Quality improvement

Indexed keywords

CYSTIC FIBROSIS; HUMAN; MEDICAL PRACTICE; MEDICAL SOCIETY; PATIENT CARE; PATIENT PARTICIPATION; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; STANDARDIZATION; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

CYSTIC FIBROSIS; DELIVERY OF HEALTH CARE; HUMANS; OUTPATIENT CLINICS, HOSPITAL; PATIENT CARE; PATIENT CARE TEAM; QUALITY ASSURANCE, HEALTH CARE;

EID: 70350452924     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0029-1238913     Document Type: Review

References (16)

1. Marshall B C. Overview of CFF strategic QI initiative. Presented at: Cystic Fibrosis Foundation's Learning and Leadership Collaborative: Accelerating the Rate of Improvement in CF Care June 28, 2004 Baltimore, MD
2. Nelson E C., Batalden P B., Huber T P. et al. Microsystems in health care, I: Learning from high-performing front-line clinical units. Jt Comm J Qual Improv 2002 28 472-493
3. Cystic Fibrosis Foundation. PortCF Web portal. Available at: https://www.portcf.org/educationalmaterials.asp?folder= %2FResources%2FConsensus+%26+Guidelines Accessed March 15, 2009
4. OConnor G T., Quinton H B., Sabadosa K A., Hazle L, Marshall B C. An intervention to accelerate the rate of improvement in the Cystic Fibrosis Foundation Care Center Network. JAMA 2009 submitted for publication
5. Cystic Fibrosis Foundation. Action Guide for Accelerating the Rate of Improvement in Cystic Fibrosis Care. Cystic Fibrosis Foundation, Clinical Microsystems 2006
6. de Koning H, Verver J P., van den Heuvel J, Bisgaard S, Does R J. Lean six sigma in healthcare. J Healthc Qual 2006 28 4-11
7. Clinical Microsystems Website. Available at: http://dms.dartmouth.edu/ cms/ Accessed March 1, 2009
8. Kraynack N C., Olbrych T G., McBride J T. Variation in management of CF pulmonary exacerbations among providers at a single CF center based on clinical scenarios [abstract]. Pediatr Pulmonol Suppl 2005 28 303
9. Kraynack N C., Falletta L M., McBride J T. Approach to treating exacerbations of CF lung disease as measured by clinical vignettes varies widely within and between CF centers [abstract]. Pediatr Pulmonol Suppl 2008 31 365
10. Kraynack N C., Omlor G J., Ouellette D A., Singh C M. Implementation of a pulmonary exacerbation scoring system to uniformly identify pulmonary exacerbations in children 618 years of age [abstract]. Pediatr Pulmonol Suppl 2005 28 302-303
11. Kraynack N C., Singh C M., Sheers T G., Bryson E A., McBride J T. Standardization of a pulmonary exacerbation score designed to uniformly identify pulmonary exacerbations in cystic fibrosis is associated with continued improvement in pulmonary function [abstract]. Pediatr Pulmonol Suppl 2007 42 372
12. Rosenfeld M, Emerson J, Williams-Warren J et al. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001 139 359-365
13. Fuchs H J., Borowitz D S., Christiansen D H. et al, The Pulmozyme Study Group. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994 331 637-642
14. Blumer J L., Saiman L, Konstan M W., Melnick D. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. Chest 2005 128 2336-2346
15. Rabin H R., Butler S M., Wohl M E. et al, Epidemiologic Study of Cystic Fibrosis. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004 37 400-406
16. Dakin C, Henry R L., Field P, Morton J. Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol 2001 31 436-442